Our western blot data on NRF2 expression demonstrated an increase in H1975 cells after osimertinib treatment (P = 0.017), indicating an increased antioxidant response in tumor cells induced by osimertinib treatment (Fig. 4H and Supplementary Fig. 16A, B). This evidence concerns the gene NFE2L2 and neoplasm.